USPTO serial 79114028
COMBIDIOL
Reviewed by CopyMark Law Group
Reg. 4381587Status 404
- Filing date
- Status date
- Registration date
- Aug 13, 2013
- Examiner
- EULIN, INGRID C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COMBIDIOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for treating pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders, neurological disorders, conditions and diseases, ischemia, neonatal hypoxia, neonatal hypoxic ischemic encephalopathy, brain injury, brain diseases, conditions and disorders, heart conditions, diseases and disorders, hypothermia; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders, neurological disorders, conditions and diseases, ischemia, neonatal hypoxia, neonatal hypoxic ischemic encephalopathy, brain injury, brain diseases, conditions and disorders, heart conditions, diseases and disorders, hypothermia; pure extracts of medicinal plants and herbs, namely, plant extracts for medical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GW Pharma Limited
- Other trademarks owned by GW Pharma Limited
- Other trademarks owned by GW Research Limited
- Other trademarks owned by GW Pharma Limited
- Other trademarks in Class 005
- Similar marks named COMBIDIOL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 5, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 29, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 29, 2021 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 29, 2021 | INPC | INVALIDATION PROCESSED | — |
| Nov 20, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Aug 30, 2018 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 13, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 21, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 29, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 19, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 7, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 9, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 18, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 15, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 13, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 13, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 28, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 28, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 8, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 8, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 8, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 19, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 19, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 18, 2013 | ALIE | ASSIGNED TO LIE | — |
| Apr 18, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 30, 2013 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 30, 2013 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 30, 2013 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 29, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 3, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 3, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 17, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 27, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 27, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 27, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 26, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 17, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 13, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 12, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |